Novavax, Inc. (NVAX)
| Previous Close | 226.92 |
| Open | 227.89 |
| Bid | 224.48 x 800 |
| Ask | 224.94 x 800 |
| Day's Range | 223.00 - 230.00 |
| 52 Week Range | 76.59 - 331.68 |
| Volume | 1,149,035 |
| Avg. Volume | 4,901,521 |
| Market Cap | 16.701B |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.51 |
| Earnings Date | May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 264.20 |
- Editor's PickYahoo Finance Video
Doctor reacts to U.S. travel ban changes
Baylor College of Medicine Assistant Professor Dr. Sara Andrabi joins Yahoo Finance to discuss the requirement of vaccinations for foreign travelers and other trends amid the COVID-19 pandemic.Â
- Motley Fool
I'm Sitting On a Record Amount of Cash: Here Are 5 Stocks I'm Looking to Buy
If you buy high-quality companies and hang onto them for long periods of time, your chances of growing your initial investment by leaps and bounds goes up significantly. What's more, Novavax's vaccine development platform should allow it to quickly tackle new variants and develop potential combination treatments in the future.
- CNW Group
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer, will be interviewed at Devex @ UNGA 76 on September 21 at 8:50 a.m. The event is hosted by the media outlet Devex and is taking place September 21-23 via livestream as part of its coverage of the 76th meeting of the United Nations General
